Analysis of gray zone PSA and PSAD correlated with PIRADS v2.1 in the MRI-US fusion prostate biopsy era: a retrospective bi-centre study.

Journal: International urology and nephrology
Published Date: May 8, 2025

Abstract

BACKGROUND: Multiple parameters including PSA, PSAD, and PIRADS v2.1 score, are being associated in an effort to increase the overall detection rate of clinically significant prostate cancer (csPCa). This study aims to explore gray zone PSA and PSAD correlated with PIRADS score in the detection of csPCa using MRI-US fusion prostate biopsy.

Authors

  • Michelangelo S Cobangbang
    Institute of Urology, St. Luke's Medical Center, Quezon City and Global City, Philippines. michelangelo.cobangbang@gmail.com.
  • Bryian P Paner
    Institute of Radiology, St. Luke's Medical Center, Quezon City and Global City, Philippines.
  • Jerome Kyle R San Jose
    Institute of Urology, St. Luke's Medical Center, Quezon City and Global City, Philippines.
  • Miguel Antonio D Isada
    Institute of Radiology, St. Luke's Medical Center, Quezon City and Global City, Philippines.
  • Paul Anthony L Sunga
    Institute of Urology, St. Luke's Medical Center, Quezon City and Global City, Philippines.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals